Methamphetamine withdrawal is not physically dangerous in the way alcohol or benzodiazepine withdrawal can be, but it produces intense fatigue, depression, and cravings that derail recovery if left unmanaged. Treatment combines medical monitoring in the first few days, behavioral therapies that have the strongest evidence base of any approach, nutritional repair, and sometimes off-label medications to ease specific symptoms. There is no single FDA-approved medication for meth withdrawal, so treatment relies on a combination of strategies tailored to the individual.
What Withdrawal Feels Like and How Long It Lasts
Meth withdrawal unfolds in two distinct phases. The acute phase begins within 24 hours of the last dose, peaks quickly, and lasts roughly 7 to 10 days. During this window, symptoms decline in a mostly linear pattern from a high initial peak. The hallmarks of this phase are excessive sleeping, increased appetite, a cluster of depression-related symptoms, and less severe but persistent anxiety and cravings.
After that first week to 10 days, a subacute phase sets in and lasts at least another two weeks, though some people experience lingering effects for one to two months. Symptoms during this stretch are generally milder but include lethargy, unstable emotions, erratic sleep patterns, and strong cravings that can come in waves. Understanding that this second phase exists helps set realistic expectations. Many people feel dramatically better after the first week and assume they’re in the clear, only to be caught off guard by cravings or low mood weeks later.
The First 72 Hours: Medical Monitoring
The earliest days of withdrawal carry the highest symptom burden. People coming off heavy or prolonged use may present with elevated heart rate, high blood pressure, and sometimes elevated body temperature. Overheating in particular can increase the risk of irregular heart rhythms and neurological harm, so cooling measures and close vital-sign monitoring matter during this window.
Inpatient or residential settings offer a significant advantage during this period. Research comparing outcomes found that people in inpatient programs were three times more likely to complete treatment than those in outpatient care. That doesn’t mean outpatient is ineffective, but if you or someone you care about has a history of heavy daily use, co-occurring mental health conditions, or previous failed attempts at quitting, a supervised environment during at least the first week can make the difference between riding out the worst symptoms and relapsing before they subside.
Your Brain Is Already Healing
One of the most encouraging findings in meth recovery research is how quickly the brain begins to bounce back. Meth depletes stored dopamine, the chemical messenger behind motivation, pleasure, and reward. Brain imaging studies show that within about 10 days of abstinence, dopamine storage levels can return to normal ranges. This is a meaningful timeline to keep in mind: the flat, joyless feeling of the first week is not a permanent state. It reflects a temporary chemical deficit that begins correcting itself faster than most people expect.
That said, full cognitive recovery, including improvements in memory, attention, and impulse control, takes longer and varies by person. But the biological trajectory bends toward healing almost immediately.
Medications That Can Help
No medication is specifically approved for meth withdrawal, but several have shown promise in clinical trials for reducing cravings and supporting recovery.
- Bupropion (an antidepressant that acts on dopamine pathways) reduced cravings and decreased meth use in clinical trials, particularly among people with lighter baseline use. It addresses both the mood and craving components of withdrawal.
- Naltrexone (commonly used in alcohol and opioid treatment) significantly reduced cravings and blunted the rewarding effects of stimulants in controlled studies. It appears to be one of the more promising options currently available.
- Modafinil (a wakefulness-promoting agent) decreased cravings in a pilot study, which may help with the crushing fatigue and low motivation of early recovery.
A prescribing clinician will choose medications based on your symptom profile. If anxiety or insomnia dominates, different short-term options may be offered. If depression is the primary barrier, an antidepressant may be started during the acute phase. The key point is that medication plays a supporting role. It takes the edge off specific symptoms while behavioral treatment does the heavier lifting.
Contingency Management: The Strongest Evidence
Of all psychosocial treatments for stimulant use, contingency management (CM) has the largest effect size. It works on a straightforward principle: you receive immediate, tangible rewards (gift cards, vouchers, prize draws) each time you provide a drug-free urine sample. This creates a competing source of positive reinforcement that stands in for the reward meth used to provide, buying time for the longer-term benefits of recovery, like stable employment and repaired relationships, to take hold.
A meta-analysis covering outcomes up to one year after treatment ended found that people who received contingency management were 1.22 times more likely to remain abstinent at follow-up compared to those receiving other therapies. That effect persisted even after the incentives stopped, with a median follow-up of 24 weeks post-treatment. Most of the research behind these numbers specifically studied stimulant users, making it directly relevant to meth recovery.
Contingency management programs are increasingly available through VA health systems, community treatment centers, and some state Medicaid programs. If you’re evaluating treatment options, asking whether a program offers CM is one of the most useful questions you can ask.
Behavioral Activation for Anhedonia
One of the hardest symptoms to manage in meth withdrawal is anhedonia, the inability to feel pleasure from things that used to be enjoyable. Food tastes flat, hobbies feel pointless, social interactions feel hollow. This isn’t a character flaw. It’s a predictable consequence of a reward system that was flooded with dopamine and is now recalibrating.
Behavioral activation (BA) directly targets this problem. Originally developed for depression, BA involves monitoring your daily activities, identifying avoidance patterns (skipping social events, staying in bed, abandoning hobbies), and systematically scheduling rewarding activities tied to your personal values. That might mean committing to a daily walk, rejoining a sports league, volunteering, or simply keeping a log of activities and rating your mood afterward so you can see the connection between doing things and feeling better.
The core insight is that motivation often follows action rather than preceding it. Waiting until you “feel like” doing something can mean waiting indefinitely during early recovery. Scheduling the activity first, even when it feels mechanical, gradually rebuilds the brain’s ability to associate everyday experiences with reward.
Sleep Problems in Early Recovery
Sleep disturbances during meth withdrawal swing between two extremes. In the first few days, hypersomnia dominates. People sleep 12 to 18 hours a day as the body crashes from prolonged stimulant-driven wakefulness. This is normal and should be allowed to run its course. Trying to fight it or maintain a “productive” schedule in the first three to four days is counterproductive.
After the initial crash, erratic sleep patterns often persist for weeks. You might fall asleep easily but wake at 3 a.m., or find yourself unable to fall asleep until dawn. Clinical guidelines from the World Health Organization recommend a quiet, calm environment during withdrawal management, with opportunities for rest, moderate physical activity like walking, and calming practices such as meditation. Standard sleep hygiene principles apply: consistent wake times (even if sleep onset varies), no screens in the hour before bed, cool and dark sleeping environments, and avoiding caffeine after midday. If insomnia is severe, short-term symptomatic medication may be offered on a case-by-case basis.
Nutrition and Physical Recovery
Meth use reliably produces malnutrition. People who use stimulants chronically tend to be deficient in a wide range of vitamins and minerals, including B vitamins (thiamin, riboflavin, B6, folate), vitamins A, C, D, and E, along with iron, calcium, zinc, magnesium, selenium, and potassium. Several of these deficiencies directly worsen depression and cognitive impairment, which are already prominent during withdrawal.
Replenishing these nutrients doesn’t require a complicated supplement regimen. Eating regular, balanced meals is the single most impactful step, and the increased appetite during acute withdrawal actually helps here. Prioritize protein-rich foods, since the amino acids tyrosine and phenylalanine serve as raw building blocks for dopamine production. Eggs, chicken, fish, beans, nuts, and dairy are all good sources. A general multivitamin can help fill gaps while eating habits stabilize.
Iron deficiency and iron-deficiency anemia are particularly common among women who use stimulants. If fatigue persists well beyond the acute phase, it’s worth getting iron levels checked rather than assuming it’s purely psychological.
Putting It Together
Effective meth withdrawal treatment layers multiple approaches: medical supervision during the acute crash, behavioral therapies (especially contingency management) to sustain abstinence, behavioral activation to rebuild the ability to experience pleasure, nutritional support to reverse deficiencies, and possibly medication to manage cravings or mood. The first 10 days are the steepest climb, but they’re also the period of fastest biological recovery. The subacute phase that follows is less intense but requires patience, structure, and ongoing support to navigate without relapse.